|Articles|October 2, 2021
Using ML, AI and RWD to Infer HCP Specialties
Author(s)IPM.ai
Pharmaceutical sales operations teams often rely on outdated or inaccurate data when prioritizing HCP targets, limiting promotional effectiveness. By applying artificial intelligence and machine learning to real world data, pharmaceutical companies can more effectively target physicians hiding in plain sight and PCPs behaving like specialists.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
2
FDA Approves Auvelity for Treatment of Agitation Associated with Dementia Due to Alzheimers
3
Using a Customer-Based Process to Synchronize Sales & Marketing Organizations in Pharma
4
Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote
5